GlassScriptPhysician profile
Christopher K Robertson
NPI 1629166517
$3,915.78
in general payments reported to CMS, 2019-2025
45 companies · $585 in 2025
The $585 reported for 2025 was more than what 76% of Family Medicine providers received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $319 · 2020: $498 · 2021: $1,039 · 2022: $592 · 2023: $340 · 2024: $542 · 2025: $585.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,467.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,466.86 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Lilly USA, LLC | $528.24 | 2020-2025 | Mounjaro, Zepbound, Jardiance |
| Abbvie INC. | $377.18 | 2021-2025 | Qulipta, Vraylar |
| Takeda Pharmaceuticals U.S.A., INC. | $298.35 | 2020-2021 | |
| Allergan, INC. | $297.39 | 2019-2020 | |
| Astrazeneca Pharmaceuticals LP | $262.66 | 2019-2025 | Farxiga, Breztri, Airsupra |
| Jazz Pharmaceuticals INC. | $168.17 | 2020-2021 | |
| Novo Nordisk INC | $150.57 | 2020-2025 | Rybelsus, Ozempic |
| Pfizer INC. | $143.55 | 2022-2025 | |
| Bayer Healthcare Pharmaceuticals INC. | $128.18 | 2022-2023 | |
| Otsuka America Pharmaceutical, INC. | $120.99 | 2022-2025 | Rexulti |
| Shire North American Group INC | $108.20 | 2019 | |
| Abbott Laboratories | $91.01 | 2022-2023 | Freestyle Libre 3 |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $89.62 | 2022-2025 | Caplyta |
| Exact Sciences Corporation | $89.17 | 2024-2025 | Cologuard Collection Kit |
| Eisai INC. | $77.66 | 2020-2021 |
Show all 45 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Christopher Robertson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.